脈衝生物科學公司
US ˙ NasdaqCM ˙ US74587B1017

簡介

本頁面提供了有關 Maky Zanganeh 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Maky Zanganeh已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:SMMT / Summit Therapeutics Inc. Co-Chief Executive Officer, Director, 10% Owner 25,824,474
US:PLSE / Pulse Biosciences, Inc. Director 725,395
US:PCYC / Pharmacyclics Chief Operating Officer 0
如何解讀這些圖表

以下圖表顯示了在Maky Zanganeh進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

PLSE / Pulse Biosciences, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 PLSE / Pulse Biosciences, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2020-06-23 PLSE Zanganeh Maky 1,193 10.7017 1,193 10.7017 12,767 230 44.2700 40,047 313.68
2020-06-17 PLSE Zanganeh Maky 7,950 7.0100 7,950 7.0100 55,730
2017-12-13 PLSE Zanganeh Maky 1,100 23.9800 1,100 23.9800 26,378
2017-12-12 PLSE Zanganeh Maky 1,000 23.9790 1,000 23.9790 23,979
2017-12-11 PLSE Zanganeh Maky 3,000 22.7630 3,000 22.7630 68,289
2017-09-18 PLSE Zanganeh Maky 7,775 15.0213 7,775 15.0213 116,791
2017-09-14 PLSE Zanganeh Maky 13,000 12.2263 13,000 12.2263 158,942
2017-09-14 PLSE Zanganeh Maky 9,000 13.5486 9,000 13.5486 121,937
2017-08-03 PLSE Zanganeh Maky 6,000 23.2270 6,000 23.2270 139,362
2017-08-03 PLSE Zanganeh Maky 9,500 23.8900 9,500 23.8900 226,955
2017-08-03 PLSE Zanganeh Maky 5,000 23.0030 5,000 23.0030 115,015
2017-08-02 PLSE Zanganeh Maky 8,290 25.1470 8,290 25.1470 208,469
2017-05-11 PLSE Zanganeh Maky 15,000 20.8360 15,000 20.8360 312,540
2017-05-10 PLSE Zanganeh Maky 5,000 21.7090 5,000 21.7090 108,545
2017-05-09 PLSE Zanganeh Maky 33,760 20.1570 33,760 20.1570 680,500
2017-03-20 PLSE Zanganeh Maky 5,000 22.4720 5,000 22.4720 112,360
2017-03-20 PLSE Zanganeh Maky 3,240 22.7080 3,240 22.7080 73,574
2017-03-20 PLSE Zanganeh Maky 1,040 23.7800 1,040 23.7800 24,731
2017-03-20 PLSE Zanganeh Maky 2,000 22.3700 2,000 22.3700 44,740
2017-03-20 PLSE Zanganeh Maky 1,000 22.3800 1,000 22.3800 22,380
2017-03-17 PLSE Zanganeh Maky 8,960 23.9960 8,960 23.9960 215,004
2017-03-17 PLSE Zanganeh Maky 2,000 23.9300 2,000 23.9300 47,860
2017-02-15 PLSE Zanganeh Maky 13,000 11.9730 13,000 11.9730 155,649
2017-02-15 PLSE Zanganeh Maky 6,200 12.1520 6,200 12.1520 75,342
2017-02-14 PLSE Zanganeh Maky 9,500 12.1190 9,500 12.1190 115,130
2017-02-13 PLSE Zanganeh Maky 2,000 11.2500 2,000 11.2500 22,500
2017-02-13 PLSE Zanganeh Maky 1,000 10.9660 1,000 10.9660 10,966

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PLSE / Pulse Biosciences, Inc. Insider Trades
PLSE / Pulse Biosciences, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 PLSE / Pulse Biosciences, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PLSE / Pulse Biosciences, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Maky Zanganeh 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-06-04 2026-06-04 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 100,000 25,824,474 0.39 14.60 1,460,000 377,037,320
2025-10-23 2025-10-21 4 SMMT Summit Therapeutics Inc.
Common Stock
A - Award 13,980,789 570,073,879 2.51 18.74 261,999,986 10,683,184,492
2025-10-23 2025-10-21 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 26,680 76,680 53.36 18.74 499,983 1,436,983
2025-10-23 2025-10-21 4 SMMT Summit Therapeutics Inc.
Common Stock
A - Award 266,808 25,724,474 1.05 18.74 4,999,982 482,076,643
2025-09-11 2025-09-11 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 5,000 556,093,090 0.00 18.07 90,350 10,048,602,136
2025-09-11 2025-09-10 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 333,394 556,088,090 0.06 17.68 5,894,406 9,831,637,431
2025-06-02 2025-05-30 4 SMMT Summit Therapeutics Inc.
Common Stock
M - Exercise 74,545 555,754,696 0.01 2.64 196,799 1,467,192,397
2025-04-09 2025-04-08 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 3,985,055 555,680,151 0.72 1.58 6,296,387 877,974,639
2025-02-11 2025-02-03 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 30,121 725,395 4.33 11.00 331,331 7,979,345
2025-02-11 2025-01-24 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 30,121 695,274 4.53 11.00 331,331 7,648,014
2024-10-03 2024-10-03 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 315,681 10,199,776 3.19 1.58 498,776 16,115,646
2024-09-13 2024-09-11 4 SMMT Summit Therapeutics Inc.
Common Stock
A - Award 44,052 24,967,852 0.18 22.70 999,980 566,770,240
2024-07-09 2024-07-03 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 60,242 665,153 9.96
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 20,000 50,000 66.67 3.71 74,200 185,500
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 34,321 24,923,800 0.14 3.72 127,674 92,716,536
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 26,000 520,814 5.25 3.72 96,720 1,937,428
2024-03-27 2024-03-26 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 30,000 30,000 3.75 112,500 112,500
2023-12-13 2023-12-12 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 5,000 494,814 1.02 2.07 10,350 1,024,265
2023-12-13 2023-12-11 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 315,681 24,889,479 1.28 1.58 498,776 39,325,377
2023-12-13 2023-12-11 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 489,814 489,814 1.44 705,332 705,332
2023-11-15 2023-11-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
M - Exercise 56,075 604,911 10.22 2.14 120,000 1,294,510
2023-11-15 2023-11-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
M - Exercise 20,000 548,836 3.78 2.14 42,800 1,174,509
2023-07-06 2023-06-09 4/A PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86,668 528,836 19.60 2.05 177,669 1,084,114
2023-06-13 2023-06-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86,668 791,915 12.29 2.05 177,669 1,623,426
2023-03-13 2023-03-08 4/A SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 6,748,629 9,884,095 215.24 1.05 7,086,060 10,378,300
2023-03-13 2023-03-08 4/A SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 16,778,415 24,573,798 215.24 1.05 17,617,336 25,802,488
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 6,748,629 9,884,095 215.24 1.05 7,086,060 10,378,300
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 804,672 1,178,529 215.24 1.05 844,906 1,237,455
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 15,973,743 23,395,269 215.24 1.05 16,772,430 24,565,032
2022-12-09 2022-12-06 4 SMMT Summit Therapeutics Inc.
Common Stock
J - Other 373,857 10,930,849 3.54
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 1,030,925 3,135,466 48.99 0.97 999,997 3,041,402
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 4,593,777 7,061,557 186.15 0.97 4,455,964 6,849,710
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 184,430 359,969 105.06 0.97 178,897 349,170
2022-06-10 2022-06-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86,668 442,168 24.38
2022-05-23 2022-05-19 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 56,075 56,075
2022-05-23 2022-05-19 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2021-12-17 2021-12-15 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2021-05-21 2021-05-20 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 8,026 8,026
2021-05-21 2021-05-20 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2021-05-14 2021-05-12 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 389,077 2,643,319 17.26 5.24 2,038,763 13,850,992
2021-01-21 2021-01-19 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
X - Other -307 0 -100.00
2021-01-21 2021-01-19 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 307 107,074 0.29 7.01 2,152 750,589
2021-01-21 2021-01-08 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
X - Other -3,000 0 -100.00
2021-01-21 2021-01-08 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 3,000 355,500 0.85 7.01 21,030 2,492,055
2020-11-24 2020-11-22 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 2,400,000 3,724,499 181.20
2020-11-13 2020-11-11 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 3,323 1,324,500 0.25
2020-11-13 2020-11-11 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 200,000 1,321,177 17.84
2020-11-13 3 SMMT Summit Therapeutics Inc.
Common Stock
2,254,242
2020-11-13 3 SMMT Summit Therapeutics Inc.
Common Stock
2,104,541
2020-06-25 2020-06-23 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,193 106,767 1.13 10.70 12,767 1,142,588
2020-06-19 2020-06-17 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 7,950 105,574 8.14 7.01 55,730 740,074
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
P - Purchase 307 307
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
P - Purchase 3,000 3,000
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 2,050 97,624 2.14 7.01 14,370 684,344
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 20,000 352,500 6.02 7.01 140,200 2,471,025
2020-05-19 2020-05-18 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 14,071 14,071
2020-05-19 2020-05-18 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2019-05-17 2019-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 9,210 9,210
2019-05-17 2019-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2019-01-09 2019-01-07 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 2,364 2,364
2018-05-24 2018-05-23 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2018-03-28 3/A PLSE Pulse Biosciences, Inc.
Common Stock
11,500
2018-03-28 3/A PLSE Pulse Biosciences, Inc.
Common Stock
5,800
2018-03-28 2017-03-20 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,000 14,000 7.69 22.38 22,380 313,320
2018-03-28 2017-03-20 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2,000 27,000 8.00 22.37 44,740 603,990
2018-03-28 2017-03-17 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2,000 25,000 8.70 23.93 47,860 598,250
2018-03-28 2017-02-15 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 6,200 13,000 91.18 12.15 75,342 157,976
2018-03-28 2017-02-14 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9,500 23,000 70.37 12.12 115,130 278,737
2018-03-28 2017-02-13 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,000 6,800 17.24 10.97 10,966 74,569
2018-03-28 2017-02-13 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2,000 13,500 17.39 11.25 22,500 151,875
2017-12-15 2017-12-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,100 95,574 1.16 23.98 26,378 2,291,865
2017-12-13 2017-12-12 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,000 94,474 1.07 23.98 23,979 2,265,392
2017-12-13 2017-12-11 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 3,000 93,474 3.32 22.76 68,289 2,127,749
2017-11-06 2017-11-02 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2017-09-18 2017-09-18 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 7,775 332,500 2.39 15.02 116,791 4,994,582
2017-09-18 2017-09-14 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9,000 324,725 2.85 13.55 121,937 4,399,569
2017-09-18 2017-09-14 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 13,000 315,725 4.29 12.23 158,942 3,860,149
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5,000 90,474 5.85 23.00 115,015 2,081,173
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9,500 302,725 3.24 23.89 226,955 7,232,100
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 6,000 293,225 2.09 23.23 139,362 6,810,737
2017-08-04 2017-08-02 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 8,290 287,225 2.97 25.15 208,469 7,222,847
2017-05-18 2017-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2017-05-11 2017-05-11 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 15,000 278,935 5.68 20.84 312,540 5,811,890
2017-05-11 2017-05-10 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5,000 85,474 6.21 21.71 108,545 1,855,555
2017-05-11 2017-05-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 33,760 80,474 72.27 20.16 680,500 1,622,114
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1,040 46,714 2.28 23.78 24,731 1,110,859
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 3,240 45,674 7.64 22.71 73,574 1,037,165
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5,000 263,935 1.93 22.47 112,360 5,931,147
2017-03-20 2017-03-17 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 8,960 42,434 26.77 24.00 215,004 1,018,246
2017-02-22 2017-02-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 13,000 33,474 63.50 11.97 155,649 400,784
2017-02-13 2017-02-09 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 45,000 45,000
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
538,344
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
299,883
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
538,344
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
299,883
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -40,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -100,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -100,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -25,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -10,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -10,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -30,000 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -114,069 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -37,500 0 -100.00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -725 0 -100.00 261.25 -189,406
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -900 0 -100.00 261.25 -235,125
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -75,363 0 -100.00 261.25 -19,688,584
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -351,293 0 -100.00 261.25 -91,775,296
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
D - Sale to Issuer -15,000 351,293 -4.10 261.25 -3,918,750 91,775,296
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -92,500 37,500 -71.15
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -48,219 0 -100.00
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 48,219 366,031 15.17 2.30 110,904 841,871
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 92,500 317,812 41.05 0.75 69,375 238,359
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -30,000 114,069 -20.82
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Common Stock
S - Sale -30,000 225,312 -11.75 254.11 -7,623,444 57,255,114
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 30,000 255,312 13.31 7.19 215,700 1,835,693
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -92,500 37,500 -71.15
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -48,219 0 -100.00
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise -48,219 366,031 -11.64 2.30 -110,904 841,871
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 92,500 317,812 41.05 0.75 69,375 238,359
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -30,000 114,069 -20.82
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -30,000 225,312 -11.75 254.11 -7,623,444 57,255,114
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 30,000 255,312 13.31 7.19 215,700 1,835,693
2015-01-21 2015-01-16 4 PCYC PHARMACYCLICS INC
Common Stock
A - Award 15,000 225,312 7.13
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -5,931 144,069 -3.95
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -658 210,312 -0.31 137.50 -90,475 28,917,900
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5,273 210,970 -2.44 138.01 -727,741 29,116,539
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 5,931 216,243 2.82 7.19 42,644 1,554,787
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -23,000 48,219 -32.29
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -6,476 210,312 -2.99 133.88 -866,997 28,156,255
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5,000 216,788 -2.25 133.76 -668,808 28,997,910
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -8,524 221,788 -3.70 133.94 -1,141,722 29,706,728
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -3,000 230,312 -1.29 133.50 -400,500 30,746,652
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 23,000 233,312 10.94 2.30 52,900 536,618
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -1,551 71,219 -2.13
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -1,551 210,312 -0.73 135.01 -209,401 28,394,223
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 1,551 211,863 0.74 2.30 3,567 487,285
2014-11-04 2014-10-31 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 1 210,312 0.00 80.93 81 17,020,235
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -5,000 72,770 -6.43
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5,000 210,311 -2.32 122.00 -610,000 25,657,942
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 5,000 215,311 2.38 2.30 11,500 495,215
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -7,000 77,770 -8.26
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5,000 210,311 -2.32 121.10 -605,500 25,468,662
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -2,000 215,311 -0.92 122.74 -245,480 26,427,272
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 7,000 217,311 3.33 2.30 16,100 499,815
2014-05-01 2014-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 204 210,311 0.10 80.39 16,400 16,906,901
2014-04-04 2014-04-02 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
A - Award 40,000 40,000
2013-12-18 2013-12-16 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -20,000 210,107 -8.69 107.55 -2,151,000 22,597,008
2013-05-01 2013-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 2,012 230,107 0.88 10.56 21,241 2,429,240
2012-10-29 2012-10-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
A - Award 100,000 100,000
2012-05-02 2012-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 2,012 228,095 0.89 10.56 21,241 2,407,999
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
206,083
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
75,636
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
725
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
900
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)